At ₹59 per tablet, Hetero Labs to sell drug for coronavirus treatment

The drug is approved to treat mild to moderate COVID-19.Hetero is also among the drugmakers that have a license with U.S.-based Gilead Sciences Inc to make remdesivir

from Livemint - Science https://ift.tt/3faL8cO